FTC sues big pharmacy profit supervisors above insulin rates The company introduced motion towards Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating practices “artificially inflated” the listing price of lifestyle-saving insulin drugs. Don't overlook tomorrow's healthcare marketplace news Permit Healthcare Dive's absolutely free newsletter... https://arizonahardteacarbs52729.bloguetechno.com/healthcare-news-things-to-know-before-you-buy-65959747